Insider Transactions in Q3 2021 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
293
-1.15%
|
$10,548
$36.87 P/Share
|
|
Sep 27
2021
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
646
-0.85%
|
$23,256
$36.87 P/Share
|
|
Sep 27
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
293
-1.88%
|
$10,548
$36.87 P/Share
|
|
Sep 13
2021
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-59.09%
|
$787,500
$35.0 P/Share
|
|
Sep 13
2021
|
Thomas Catinazzo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+37.14%
|
$90,000
$4.12 P/Share
|
|
Sep 13
2021
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,500
-20.26%
|
$227,500
$35.02 P/Share
|
|
Sep 13
2021
|
Brian Adams Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+16.85%
|
$26,000
$4.12 P/Share
|